A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
Santeusanio, F
A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus. [electronic resource] - Drug safety Dec 1994 - 432-44 p. digital
Publication Type: Journal Article; Review
0114-5916
10.2165/00002018-199411060-00005 doi
Acarbose
Animals
Blood Glucose--analysis
Clinical Trials as Topic
Diabetes Mellitus, Type 2--drug therapy
Disease Models, Animal
Glycoside Hydrolase Inhibitors
Humans
Hypoglycemic Agents--administration & dosage
Intestinal Absorption--drug effects
Risk Assessment
Trisaccharides--administration & dosage
A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus. [electronic resource] - Drug safety Dec 1994 - 432-44 p. digital
Publication Type: Journal Article; Review
0114-5916
10.2165/00002018-199411060-00005 doi
Acarbose
Animals
Blood Glucose--analysis
Clinical Trials as Topic
Diabetes Mellitus, Type 2--drug therapy
Disease Models, Animal
Glycoside Hydrolase Inhibitors
Humans
Hypoglycemic Agents--administration & dosage
Intestinal Absorption--drug effects
Risk Assessment
Trisaccharides--administration & dosage